Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
126.00    -1.60 (-1.25%)
Bid:
125.20
Ask:
126.00
Spread: 0.80 (0.639%)
Market Cap: £524.68m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Pre-close Trading Statement

26 Jul 2011 07:00

RNS Number : 0254L
James Halstead PLC
26 July 2011
 



 

 

26 July 2011

 

James Halstead plc

 

Pre-close Trading Statement

 

"Continues robust trading and confident of reporting record profit"

 

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update prior to entering the close period ahead of its results for the year to 30 June 2011.

 

In its interim results statement issued on 31 March 2011, the Company stated that: "The first half year trading was very solid with record revenue representing an increase of 15.2%. The Chairman, Mr. Geoffrey Halstead expressed confidence that the Company would forge ahead in the second half year.

 

Overall, this confidence was well founded and the Company has continued to trade robustly. Trading performances across the Company's export markets have remained strong and overall turnover should have increased by around 15%. The growth in our export markets is particularly strong and it is too simplistic to put this down to the value of sterling. Our exports have grown over a generation and we are well placed to continue supplying flooring to major infrastructure projects across the globe.

 

In the UK the commercial flooring market place has declined as might be expected in a building recession. Notwithstanding this, we expect turnover in the UK to be ahead of last year. Our home market has faced the challenges of price competition (as manufacturers look to hold on to volume) and an estimated 16% decline in the market for sheet vinyl. One of our key strengths is in refurbishment, but several large flooring contractors have gone out of business which has frustrated the smooth flow of ongoing refurbishment spending. None of this was unexpected and the UK commercial flooring market continues to be challenging.

 

Notwithstanding these problems, we have increased turnover in the UK, partly as a result of increased market share but also as a result of significant growth in sourced product which has crossed over from its target market of "light contract" into the "heavy domestic" marketplace. With the same route to market as commercial flooring, through flooring distributors, we have encouraged this expansion.

 

Rising raw material and energy costs have continued to impact on margins though there are some compensatory effects of which the most significant is improved margins on increased international sales. Our cash balances and even after dividends, acquisitions and plant expenditure it should exceed the levels of last year.

 

Riverside Flooring Ltd, the newest addition to the Group, which was acquired in November 2010, has incurred some significant costs as we tested, adapted and re-commissioned the plant. Previously the plant used to make domestic cushion vinyl.

 

Taking all the above into consideration the Board is confident that the Company will report another year of record profits for the year ended 30 June 2011 in line with market expectations.

 

Enquiries:

 

James Halstead

0161 767 2500

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Hudson Sandler

020 7796 4133

Michael Sandler

Altium

020 7484 4040

Ben Thorne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQELFLFDFXBBX
Date   Source Headline
6th Jun 20124:40 pmRNSSecond Price Monitoring Extn
6th Jun 20124:35 pmRNSPrice Monitoring Extension
1st Jun 20127:00 amRNSTotal Voting Rights
25th May 20122:00 pmRNSDirector/PDMR Shareholding
1st May 20127:00 amRNSTotal Voting Rights
2nd Apr 20123:45 pmRNSDirector/PDMR Shareholding
29th Mar 20127:00 amRNSInterim Results
12th Mar 20124:35 pmRNSPrice Monitoring Extension
1st Mar 20127:00 amRNSTotal Voting Rights
30th Jan 20127:00 amRNSPre-Close Trading Statement
11th Jan 20127:00 amRNSAppointment of Broker
4th Jan 20127:00 amRNSAppointment of non-executive director
3rd Jan 20127:00 amRNSBlocklisting Interim Review
3rd Jan 20127:00 amRNSTotal Voting Rights
6th Dec 20111:00 pmRNSDirector's shareholding
5th Dec 20114:45 pmRNSChange in shareholdings
2nd Dec 20117:00 amRNSAGM Statement
30th Nov 201110:50 amRNSResult of Tender Offer
14th Nov 20117:00 amRNSTender Offer and Trading Update
1st Nov 20117:00 amRNSTotal Voting Rights
28th Oct 20112:00 pmRNSAnnual Financial Report
11th Oct 201111:00 amRNSChange in Director's Holding
3rd Oct 20117:00 amRNSPreliminary Results
6th Sep 20117:00 amRNSNotice of Results
15th Aug 20117:00 amRNSTotal Voting Rights
26th Jul 20117:00 amRNSPre-close Trading Statement
6th Jul 20118:45 amRNSDirector/PDMR Shareholding
1st Jul 20117:00 amRNSBlocklisting Interim Review
3rd May 20117:00 amRNSTotal Voting Rights
15th Apr 20112:40 pmRNSDirector/PDMR Shareholding
1st Apr 20117:00 amRNSTotal Voting Rights
31st Mar 20117:00 amRNSInterim Results
31st Jan 20112:00 pmRNSHolding(s) in Company
31st Jan 20117:00 amRNSPre-close Trading Statement
13th Jan 20113:30 pmRNSIssue of Equity and Total Voting Rights
12th Jan 20119:30 amRNSBonus Issue
4th Jan 20119:45 amRNSTotal Voting Rights
4th Jan 20119:10 amRNSBlocklisting Interim Review
21st Dec 20103:45 pmRNSDirector/PDMR Shareholding
3rd Dec 20107:00 amRNSAnnual General Meeting
1st Nov 20107:00 amRNSTotal Voting Rights
25th Oct 20109:15 amRNSAnnual Report and Accounts
25th Oct 20109:15 amRNSAnnual Report and Accounts
30th Sep 20107:00 amRNSPreliminary Results
23rd Jul 20107:00 amRNSPre-Close Trading Update
1st Jul 20107:00 amRNSBlocklisting Interim Review
6th Apr 201012:00 pmRNSTotal Voting Rights
31st Mar 20104:17 pmRNSDirector/PDMR Shareholding
31st Mar 20107:00 amRNSInterim Results
1st Mar 20107:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.